 MIAMI, Sept. 06, 2022 GLOBE NEWSWIRE -- Veru Inc. NASDAQ: VERU, a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral and ARDS-related diseases and for the management of breast and prostate cancers, today announced that the Company will present at the H.C. Wainwright 24th Annual Global Investment Conference. The presentation will be available through the Conference on September 12, 2022, starting at 7:00 AM Eastern Daylight Time. 